Search for "DCGI"

Covid-19: India’s 1st mRNA Omicron Booster Dose Gets DCGI Nod – Check Expected Launch Date

Vaccines offer protection from severe illness and hospitalization

The vaccine was evaluated for its safety and immunogenicity as a booster in about 3,000 people from across 13 cities in India who received two doses of Covishield and Covaxin.

View Post

India’s Gennova Receives DCGI Approval for Omicron-Specific mRNA Booster Vaccine

GEMCOVAC®-OM reinforces the importance of vaccination against the coronavirus

Pune-based Gennova Biopharmaceuticals Receives Approval for Omicron-Specific mRNA Booster Vaccine Pune, India – Gennova Biopharmaceuticals Ltd, a leading biotechnology company in India, announced today that it has received Emergency Use…

View Post

We Are Waiting For DCGI Approval For Children’s Covid-19 Vaccine: Bharat Biotech Chairman

Dr. Krishna Ella the chairman and Managing Director of Bharat Biotech on Saturday announced that they are waiting for approval from the Drugs Controller General of India (DCGI) for the…

View Post

DCGI Gives Nod To AstraZeneca Pharma India To Import, Market Selumetinib Capsules

Drug firm AstraZeneca Pharma India has received import and market permission from the Indian drug regulator for Selumetinib capsules. AstraZeneca Pharma India said in a regulatory filing, the company has…

View Post

Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials, May Submit Data To DCGI By Next Week

The Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age has been completed by Bharat Biotech and is expected to submit the data…

View Post

Sputnik’s Single-Dose Vaccine Gets DCGI Nod For Phase-III Trials In India

The Drugs Controller General of India (DCGI) has granted authorization for the conducting of the Phase III bridging trials of the Sputnik Light vaccine on the Indian population. The Sputnik…

View Post

Cipla Gets DCGI Nod To Import Moderna’s Covid Vaccine For Restricted Emergency Use In India: Sources

Official sources on Tuesday informed that India’s drug regulator DCGI has approved permission to Mumbai-based pharmaceutical company Cipla to import Moderna’s coronavirus vaccine for restricted emergency use in the country.…

View Post

Menu

DCGI

Covid-19: India’s 1st mRNA Omicron Booster Dose Gets DCGI Nod – Check Expected Launch Date

India’s Gennova Receives DCGI Approval for Omicron-Specific mRNA Booster Vaccine

We Are Waiting For DCGI Approval For Children’s Covid-19 Vaccine: Bharat Biotech Chairman

DCGI Gives Nod To AstraZeneca Pharma India To Import, Market Selumetinib Capsules

Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials, May Submit Data To DCGI By Next Week

Sputnik’s Single-Dose Vaccine Gets DCGI Nod For Phase-III Trials In India

Cipla Gets DCGI Nod To Import Moderna’s Covid Vaccine For Restricted Emergency Use In India: Sources

Walking Pneumonia Symptoms: The Silent Respiratory Illness You Could Be Overlooking

Diabetes Treatment Breakthrough: Canagliflozin Improves Kidney Oxygenation, Shows Study

AIIMS Discovers New Drug Combo to Control Hypertension More Effectively

What Is Clade I Mpox? Symptoms of the Newly Detected Variant in the US

How Smoking and Pollution Fuel the COPD Crisis, doctor Explains

WHO Lists LC16m8 Mpox Vaccine for Emergency Use Amid Rising Cases

WHO Reports Alarming Spike in Air Pollution Deaths to 8.1 Million in 2021

How SARS-CoV-2 Manipulates Cholesterol Trafficking to Evade Immune Responses: New Study Explains